July 8, 2010 — The European Commission (EC) has approved a change in treatment duration from 3 to 13 weeks for a prolonged-release melatonin product (Circadin; Neurim Pharmaceuticals) used to combat ...
If you're over 55 and have spent more than a few sleepless nights, you're not alone -- insomnia affects about half of all people over 55 -- but you may also be at increased risk for physical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results